Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2006
08/24/2006US20060189590 Alkaline salts of proton pump inhibitors
08/24/2006US20060189589 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease
08/24/2006US20060189588 Process for producing unsaturated fatty acid-containing oils
08/24/2006US20060189587 Use for budesonide and formoterol
08/24/2006US20060189586 Pharmaceutical compositions comprising active vitamin D compounds
08/24/2006US20060189585 Dosage and method for attaining beneficial levels of vitamin D3
08/24/2006US20060189584 Pharmaceutical combinations
08/24/2006US20060189583 Aryl dicarboxamides
08/24/2006US20060189582 Compositions and methods for treatment of disorders of protein aggregation
08/24/2006US20060189581 Compounds and methods for treating transplant rejection
08/24/2006US20060189580 1-Adamantyl chalcones for the treatment of proliferative disorders
08/24/2006US20060189579 Method of stabilizing ascorbyl phosphate and salts thereof
08/24/2006US20060189578 Method for the synthesis of compounds of formula I and their uses thereof
08/24/2006US20060189577 Tyrosine kinase inhibitors
08/24/2006US20060189576 Substituted vitamin d analogues and their therapeutic uses
08/24/2006US20060189575 Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels
08/24/2006US20060189574 Method of treating high plasma cholesterol levels
08/24/2006US20060189573 Solutions and films of glycated chitosan
08/24/2006US20060189572 Composition for local anesthesia
08/24/2006US20060189571 Use of lipid conjugates in the treatment of infection
08/24/2006US20060189570 Use of lipid conjugates in the treatment of infection
08/24/2006US20060189569 Administering complex of drug and phospholipid
08/24/2006US20060189568 Administering complex of drug and phospholipid; influenza
08/24/2006US20060189567 Compound having affinity with calcified tissue
08/24/2006US20060189566 Muscle building agent and preventive or remedy for muscle weakening
08/24/2006US20060189565 Pharmaceutical compositions of ganciclovir
08/24/2006US20060189562 In vitro-differentiated retinal ganglion cells and method for producing same
08/24/2006US20060189558 Delivery of substances to cells
08/24/2006US20060189556 Genes encoding Mycobacterium bovis bacillus Calmette-Guerin (M. bovis BCG) recombinant antigens and those for interleukin-12 heterodimer were respectively cloned into eukaryotic expression vectors; attenuating or suppressing the growth of bladder cancer cells
08/24/2006US20060189555 Pyrroles substituted by oligonucleotides
08/24/2006US20060189552 Dispenser for dispensing three or more actives
08/24/2006US20060189551 Combination therapies for fungal pathogens
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006US20060189548 inhibiting sodium-dependent glucose cotransporter SGLT2; diabetes mellitus, metabolic acidosis or ketosis, reactive hypoglycaemia, hyperinsulinaemia, glucose metabolic disorder, insulin resistance, metabolic syndrome, dyslipidaemias, atherosclerosis, obesity, high blood pressure, chronic heart failure
08/24/2006US20060189547 Novel pharmaceutical agents containing carbohydrate moieties and methods of their preparation and use
08/24/2006US20060189546 Compounds for treating autoimmune and demyelinating diseases
08/24/2006US20060189545 Novel chemical entities and methods for their use in treatment of metabolic disorders
08/24/2006US20060189544 Integrin-Mediated drug targeting
08/24/2006US20060189543 Compositions and methods for the treatment of leukemia
08/24/2006US20060189542 Preventive or therapeutic composition for viral infectious disease
08/24/2006US20060189541 Methods of treating dry eye disorders
08/24/2006US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
08/24/2006US20060189536 Treating the effects of nicotine
08/24/2006US20060189535 Combination treatment using exendins and thiazolidinediones
08/24/2006US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences
08/24/2006US20060189526 Compositions containing an intestinal trefoil peptide and a mucoadhesive
08/24/2006US20060189524 Pharmaceutical compositions based on anticholinergics and pegsunercept
08/24/2006US20060189523 Use of effectors of glutaminyl and glutamate cyclases
08/24/2006US20060189512 Compositions containing botanical extracts rich in phlorizin and methods for using such compositions in blood glucose modification and to affect aging
08/24/2006US20060189511 Method for cytoprotection through mdm2 and hdm2 inhibition
08/24/2006US20060189500 Aqueous olanexidine solution, method of preparing the same, and disinfectant
08/24/2006US20060189483 Metal-containing compositions, preparations and uses
08/24/2006US20060188990 Novel prostate tumor-specific promoter
08/24/2006US20060188953 Methods and compositions that affect melanogenesis
08/24/2006US20060188938 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
08/24/2006US20060188920 Identification of compounds that inhibit replication of human immunodeficiency virus
08/24/2006US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds
08/24/2006US20060188898 Markers for roscovitine
08/24/2006US20060188866 Diaminophenothiazine compositions and uses thereof
08/24/2006US20060188592 Cyclooxygenase-3 inhibitory withanolide compositions and method
08/24/2006US20060188591 Bauhinia extracts
08/24/2006US20060188590 Compositions for treating diabetes or obesity
08/24/2006US20060188586 Compositions and methods for enhancing therapeutic effects
08/24/2006US20060188584 Composition and process for treating acne
08/24/2006US20060188581 selective irreversible inhibitor of the B-form of the enzyme monoamine oxidase used, for example, for the treatment of Parkinson's disease; R(+)-N-propargyl-1-aminoindan salts, in particular tartrate, esylate, mesylate, or sulfate salts
08/24/2006US20060188578 Hyaluronic acid nanoparticles
08/24/2006US20060188577 Element having bioactive substance fixed thereto
08/24/2006US20060188576 Pirenzepine ophthalmic gel
08/24/2006US20060188575 Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators
08/24/2006US20060188574 Controlled release lipoic acid
08/24/2006US20060188571 Mixing progesterone with water and adjuvants; drying; compaction
08/24/2006US20060188570 Making a tablet for HIV and AIDS drug efavirenz; use of a superdisintegrant and disintegrant intragranularly to achieved a bioequivalent formulation; bioavailability
08/24/2006US20060188568 Stable formulations of ace inhibitors and methods for preparation thereof
08/24/2006US20060188566 Nanoparticulate formulations of docetaxel and analogues thereof
08/24/2006US20060188565 Treating acute pain by administering a solid oral dosage of diclofenac or salt which also contains an excipient base,(alkali carbonate or bicarbonate) to generate a gaseous and alkaline environment upon ingestion;; disintegration time of <15 minutes, 5-30 minutes for maximum concentration in blood
08/24/2006US20060188563 Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
08/24/2006US20060188560 Delivery system for nucleic acids
08/24/2006US20060188559 Dermatological serum comprised of alpha arbutin, bearberry extract, octyl stearate and polyolprepolymer-2, introduced onto the human skin in liposome form for ultra-deep penetration; skin lightening
08/24/2006US20060188557 Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor
08/24/2006US20060188554 Transdermal absorption preparation
08/24/2006US20060188550 Method of production of animal nutritional product that increases weight gain and reduces diarrhea morbidity, mortality and severity by stimulation of natural immune response
08/24/2006US20060188545 Bioabsorbable composition and coatings including same
08/24/2006US20060188542 Implant improving local bone formation
08/24/2006US20060188534 Dispersions for the formulation of slightly or poorly soluble agents
08/24/2006US20060188530 Bile preparations for gastrointestinal disorders
08/24/2006US20060188529 Stable compositions of fenofibrate with fatty acid esters
08/24/2006US20060188525 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin
08/24/2006US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells
08/24/2006US20060188507 Methods for identifying chemotherapeutic resistance in non-hematopoietic tumors
08/24/2006US20060188506 Therapy-enhancing glucan
08/24/2006US20060188498 Methods of using death receptor agonists and EGFR inhibitors
08/24/2006US20060188492 Topical management of ocular and periocular conditions
08/24/2006US20060188487 Blend hydrogels and methods of making
08/24/2006US20060188475 Methods and compositions using immunomodulatory compounds for the treatment of immunodeficiency disorders
08/24/2006US20060188471 Methods of treating epithelial lesions
08/24/2006US20060188470 PES 2000 plus folic acid
08/24/2006US20060188467 Skin care composition containing a sugar amine
08/24/2006US20060188465 Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols
08/24/2006US20060188464 Microencapsulation systems and applications of same
08/24/2006US20060188463 Stable water-in-oil-in-water multiple emulsion system produced by hydrodynamic dual stabilization and a method for preparation thereof